Jesse David Roberts, Jr., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Smooth Muscle | 10 | 2019 | 696 | 1.820 |
Why?
|
| Cyclic GMP | 6 | 2024 | 395 | 1.790 |
Why?
|
| Muscle, Smooth, Vascular | 10 | 2019 | 1491 | 1.340 |
Why?
|
| Nitric Oxide | 14 | 2024 | 2133 | 1.320 |
Why?
|
| Pulmonary Artery | 8 | 2018 | 1938 | 1.190 |
Why?
|
| Cyclic GMP-Dependent Protein Kinases | 3 | 2009 | 28 | 0.950 |
Why?
|
| Aldehydes | 2 | 2022 | 170 | 0.920 |
Why?
|
| Pulmonary Alveoli | 5 | 2021 | 650 | 0.870 |
Why?
|
| Respiratory Rate | 2 | 2024 | 176 | 0.860 |
Why?
|
| Transforming Growth Factor beta | 6 | 2021 | 1960 | 0.840 |
Why?
|
| Antisocial Personality Disorder | 1 | 2023 | 224 | 0.810 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2021 | 55 | 0.780 |
Why?
|
| Guanylate Cyclase | 2 | 2013 | 205 | 0.730 |
Why?
|
| Gene Expression Regulation, Enzymologic | 4 | 2021 | 1171 | 0.730 |
Why?
|
| Lung | 10 | 2024 | 9995 | 0.710 |
Why?
|
| Culture | 1 | 2023 | 623 | 0.660 |
Why?
|
| Lung Injury | 2 | 2021 | 422 | 0.640 |
Why?
|
| Cell Nucleus | 4 | 2017 | 2908 | 0.600 |
Why?
|
| Smad5 Protein | 1 | 2017 | 26 | 0.580 |
Why?
|
| Smad1 Protein | 1 | 2017 | 81 | 0.570 |
Why?
|
| Respiration | 1 | 2024 | 1657 | 0.560 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2013 | 857 | 0.560 |
Why?
|
| Activin Receptors, Type I | 1 | 2017 | 134 | 0.550 |
Why?
|
| Furin | 2 | 2015 | 46 | 0.550 |
Why?
|
| Golgi Apparatus | 2 | 2015 | 405 | 0.500 |
Why?
|
| Animals, Newborn | 10 | 2021 | 2677 | 0.500 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2018 | 629 | 0.480 |
Why?
|
| Nuclear Localization Signals | 1 | 2014 | 77 | 0.470 |
Why?
|
| Proprotein Convertase 5 | 1 | 2013 | 3 | 0.450 |
Why?
|
| Fibroblasts | 3 | 2021 | 4140 | 0.420 |
Why?
|
| Cardiac Output | 1 | 2014 | 837 | 0.390 |
Why?
|
| Down-Regulation | 1 | 2018 | 2918 | 0.370 |
Why?
|
| Persistent Fetal Circulation Syndrome | 3 | 1997 | 80 | 0.340 |
Why?
|
| Signal Transduction | 9 | 2024 | 23441 | 0.330 |
Why?
|
| Rats | 11 | 2022 | 23742 | 0.320 |
Why?
|
| Cell Nucleolus | 1 | 2008 | 156 | 0.300 |
Why?
|
| Monitoring, Intraoperative | 1 | 2014 | 942 | 0.290 |
Why?
|
| Electrocardiography | 4 | 2024 | 6384 | 0.270 |
Why?
|
| Animals | 33 | 2024 | 168441 | 0.260 |
Why?
|
| Administration, Inhalation | 11 | 2007 | 1156 | 0.240 |
Why?
|
| Sheep | 4 | 2024 | 1440 | 0.240 |
Why?
|
| Molecular Probes | 2 | 2022 | 310 | 0.220 |
Why?
|
| Microcomputers | 1 | 2023 | 141 | 0.210 |
Why?
|
| Mice | 16 | 2023 | 81509 | 0.200 |
Why?
|
| Smad Proteins | 1 | 2021 | 156 | 0.190 |
Why?
|
| Calibration | 1 | 2023 | 818 | 0.180 |
Why?
|
| Hyperoxia | 3 | 2014 | 258 | 0.180 |
Why?
|
| Fetus | 2 | 2024 | 1864 | 0.180 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 1974 | 0.170 |
Why?
|
| NIH 3T3 Cells | 1 | 2021 | 671 | 0.170 |
Why?
|
| Cell Differentiation | 3 | 2014 | 11526 | 0.170 |
Why?
|
| Neovascularization, Physiologic | 1 | 2007 | 1344 | 0.170 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 1486 | 0.170 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2013 | 435 | 0.170 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2024 | 1496 | 0.160 |
Why?
|
| Antibodies | 1 | 2007 | 2421 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 6 | 2007 | 1580 | 0.160 |
Why?
|
| Lung Diseases | 4 | 2014 | 1909 | 0.160 |
Why?
|
| Smad2 Protein | 2 | 2009 | 145 | 0.150 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2017 | 46 | 0.140 |
Why?
|
| Cell Line | 3 | 2017 | 15605 | 0.140 |
Why?
|
| Benzodioxoles | 1 | 2017 | 75 | 0.140 |
Why?
|
| Activin Receptors, Type II | 1 | 2017 | 123 | 0.140 |
Why?
|
| Phosphorylation | 3 | 2017 | 8320 | 0.130 |
Why?
|
| Extracellular Matrix | 2 | 2021 | 1725 | 0.130 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 302 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1675 | 0.130 |
Why?
|
| Protein Transport | 2 | 2015 | 1966 | 0.130 |
Why?
|
| Educational Status | 1 | 2023 | 2520 | 0.130 |
Why?
|
| Monensin | 1 | 2015 | 30 | 0.130 |
Why?
|
| Infant, Newborn | 9 | 2024 | 26212 | 0.120 |
Why?
|
| HEK293 Cells | 2 | 2015 | 4278 | 0.120 |
Why?
|
| Cardiography, Impedance | 1 | 2014 | 40 | 0.120 |
Why?
|
| Hypertrophy, Right Ventricular | 1 | 1995 | 108 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 2019 | 983 | 0.120 |
Why?
|
| Vasodilator Agents | 3 | 2007 | 973 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2007 | 4936 | 0.110 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2015 | 200 | 0.110 |
Why?
|
| Hemodynamics | 3 | 2000 | 4168 | 0.110 |
Why?
|
| Vasoconstriction | 2 | 1993 | 592 | 0.110 |
Why?
|
| Acidosis, Respiratory | 1 | 1993 | 38 | 0.110 |
Why?
|
| Cricetulus | 1 | 2015 | 814 | 0.110 |
Why?
|
| Subtilisins | 1 | 2013 | 81 | 0.110 |
Why?
|
| Transglutaminases | 1 | 2014 | 197 | 0.100 |
Why?
|
| Reperfusion Injury | 1 | 2019 | 1023 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 7595 | 0.100 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2014 | 326 | 0.100 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2014 | 502 | 0.100 |
Why?
|
| Myofibroblasts | 1 | 2013 | 223 | 0.100 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 1780 | 0.100 |
Why?
|
| Imidazoles | 1 | 2017 | 1180 | 0.090 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2019 | 975 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 22163 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3792 | 0.090 |
Why?
|
| Pulmonary Circulation | 4 | 1994 | 743 | 0.090 |
Why?
|
| Growth Disorders | 1 | 1995 | 653 | 0.090 |
Why?
|
| Biological Transport | 1 | 2014 | 2092 | 0.090 |
Why?
|
| Software | 1 | 2024 | 4434 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2009 | 219 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2014 | 951 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2014 | 1246 | 0.080 |
Why?
|
| Brefeldin A | 1 | 2008 | 68 | 0.080 |
Why?
|
| Nocodazole | 1 | 2008 | 95 | 0.080 |
Why?
|
| Indomethacin | 1 | 1989 | 326 | 0.080 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2008 | 189 | 0.080 |
Why?
|
| Oxygen | 5 | 1994 | 4228 | 0.070 |
Why?
|
| Response Elements | 1 | 2008 | 309 | 0.070 |
Why?
|
| Liver | 1 | 2022 | 7532 | 0.070 |
Why?
|
| Aortic Aneurysm | 1 | 2011 | 648 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 3734 | 0.070 |
Why?
|
| Phosphotransferases | 1 | 2007 | 303 | 0.070 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2007 | 460 | 0.070 |
Why?
|
| Yeasts | 1 | 2007 | 279 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2009 | 943 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2009 | 12796 | 0.070 |
Why?
|
| Epithelial Cells | 2 | 2015 | 3667 | 0.060 |
Why?
|
| Cell Count | 1 | 2009 | 1835 | 0.060 |
Why?
|
| Elastin | 1 | 2007 | 298 | 0.060 |
Why?
|
| Humans | 20 | 2024 | 761423 | 0.060 |
Why?
|
| Pyridines | 1 | 2017 | 2875 | 0.060 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2005 | 92 | 0.060 |
Why?
|
| Neutralization Tests | 1 | 2007 | 728 | 0.060 |
Why?
|
| Isoenzymes | 1 | 2009 | 1688 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2015 | 18964 | 0.060 |
Why?
|
| Leukotriene B4 | 1 | 2005 | 280 | 0.060 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2005 | 150 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2008 | 1463 | 0.060 |
Why?
|
| Cell Separation | 1 | 2009 | 1721 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 16979 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 11902 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2011 | 2667 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2008 | 1511 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2007 | 2265 | 0.050 |
Why?
|
| Algorithms | 1 | 2024 | 14026 | 0.050 |
Why?
|
| Drug Interactions | 1 | 2007 | 1414 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14409 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1699 | 0.050 |
Why?
|
| Monocrotaline | 1 | 2000 | 26 | 0.050 |
Why?
|
| Cell Lineage | 1 | 2009 | 2555 | 0.050 |
Why?
|
| Gram-Negative Bacteria | 1 | 2002 | 271 | 0.040 |
Why?
|
| Interleukin-1 | 2 | 2002 | 1249 | 0.040 |
Why?
|
| Swine | 2 | 2021 | 5914 | 0.040 |
Why?
|
| Vascular Resistance | 2 | 1993 | 933 | 0.040 |
Why?
|
| Peptidoglycan | 1 | 2002 | 249 | 0.040 |
Why?
|
| Infant | 4 | 2014 | 36205 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 5794 | 0.040 |
Why?
|
| Methemoglobinemia | 2 | 1997 | 44 | 0.040 |
Why?
|
| Inhalation | 1 | 2000 | 143 | 0.040 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2002 | 406 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2002 | 803 | 0.040 |
Why?
|
| E-Selectin | 1 | 2000 | 576 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2007 | 2448 | 0.040 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 1893 | 0.040 |
Why?
|
| Stroke | 1 | 2019 | 9756 | 0.040 |
Why?
|
| Tidal Volume | 1 | 2019 | 488 | 0.030 |
Why?
|
| Lipoproteins | 1 | 2002 | 881 | 0.030 |
Why?
|
| Adult | 5 | 2024 | 221148 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 8179 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2000 | 1125 | 0.030 |
Why?
|
| Partial Pressure | 2 | 1994 | 245 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2000 | 618 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 1993 | 4696 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20093 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 17644 | 0.030 |
Why?
|
| Fibrosis | 1 | 2022 | 2048 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2014 | 42254 | 0.030 |
Why?
|
| Genome, Human | 1 | 2007 | 4425 | 0.030 |
Why?
|
| Collagen | 1 | 2022 | 2638 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1995 | 350 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1995 | 418 | 0.030 |
Why?
|
| Methemoglobin | 1 | 1992 | 25 | 0.030 |
Why?
|
| Cell Division | 1 | 2000 | 4466 | 0.030 |
Why?
|
| Blood | 1 | 1995 | 598 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1995 | 908 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 1934 | 0.020 |
Why?
|
| Multigene Family | 1 | 1995 | 1077 | 0.020 |
Why?
|
| Female | 8 | 2019 | 392581 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 794 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 371 | 0.020 |
Why?
|
| Organ Size | 1 | 1995 | 2254 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 1990 | 162 | 0.020 |
Why?
|
| Oximetry | 1 | 1992 | 460 | 0.020 |
Why?
|
| Male | 6 | 2019 | 360736 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2005 | 3407 | 0.020 |
Why?
|
| Child | 2 | 2014 | 80162 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2002 | 10766 | 0.020 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1990 | 233 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1993 | 1334 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2011 | 838 | 0.020 |
Why?
|
| Sepsis | 1 | 2002 | 2585 | 0.020 |
Why?
|
| Young Adult | 1 | 2014 | 59207 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1989 | 1317 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1995 | 4638 | 0.020 |
Why?
|
| Myocardium | 2 | 2002 | 4725 | 0.020 |
Why?
|
| Elasticity | 1 | 1989 | 655 | 0.020 |
Why?
|
| Adolescent | 1 | 2014 | 88313 | 0.020 |
Why?
|
| Mutation | 2 | 2008 | 30045 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 13637 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6532 | 0.020 |
Why?
|
| Bronchi | 1 | 1989 | 845 | 0.010 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 2004 | 117 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2005 | 215 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2014 | 2104 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1995 | 3816 | 0.010 |
Why?
|
| Galactosamine | 1 | 2002 | 26 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2005 | 652 | 0.010 |
Why?
|
| Inflammation | 1 | 2002 | 10762 | 0.010 |
Why?
|
| Nitrites | 1 | 2002 | 159 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1992 | 2625 | 0.010 |
Why?
|
| Mice, Inbred C3H | 1 | 2002 | 915 | 0.010 |
Why?
|
| Models, Animal | 1 | 2007 | 2113 | 0.010 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 1443 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9535 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10441 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1993 | 8000 | 0.010 |
Why?
|
| Cattle | 2 | 1995 | 3848 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1992 | 8487 | 0.010 |
Why?
|
| Models, Biological | 1 | 1993 | 9469 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 2295 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1995 | 422 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 2928 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 36423 | 0.010 |
Why?
|
| Escherichia coli Proteins | 1 | 2002 | 1067 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1997 | 54415 | 0.010 |
Why?
|
| Tachyphylaxis | 1 | 1994 | 54 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1993 | 18247 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 5203 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 3207 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 1992 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 11073 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1990 | 53 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4354 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1997 | 64651 | 0.010 |
Why?
|
| Minnesota | 1 | 1990 | 339 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 4174 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1990 | 149 | 0.010 |
Why?
|
| Rhode Island | 1 | 1990 | 351 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2002 | 4218 | 0.010 |
Why?
|
| Pregnancy | 1 | 2011 | 29862 | 0.010 |
Why?
|
| Texas | 1 | 1990 | 404 | 0.010 |
Why?
|
| New York City | 1 | 1990 | 731 | 0.000 |
Why?
|
| Macrophages | 1 | 2002 | 5768 | 0.000 |
Why?
|
| Cytokines | 1 | 2002 | 7392 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1994 | 4852 | 0.000 |
Why?
|
| Time Factors | 2 | 2002 | 39975 | 0.000 |
Why?
|
| Infant, Low Birth Weight | 1 | 1990 | 869 | 0.000 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 1703 | 0.000 |
Why?
|
| Base Sequence | 1 | 1995 | 12450 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1990 | 2048 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1995 | 13449 | 0.000 |
Why?
|
| Triglycerides | 1 | 1990 | 2460 | 0.000 |
Why?
|
| Survival Rate | 1 | 1993 | 12720 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 15498 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1990 | 10203 | 0.000 |
Why?
|
| Aged | 1 | 1994 | 169235 | 0.000 |
Why?
|
| Middle Aged | 1 | 1994 | 220826 | 0.000 |
Why?
|